metformin has been researched along with Anterior Cerebral Circulation Infarction in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"Metformin (200 mg/kg) was administrated for up to 14 days." | 1.40 | Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion. ( Chen, X; Gu, X; Li, Y; Liu, Y; Tang, G; Wang, Y; Yang, GY; Zhang, Z, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Grissi, M | 1 |
Boudot, C | 1 |
Assem, M | 1 |
Candellier, A | 1 |
Lando, M | 1 |
Poirot-Leclercq, S | 1 |
Boullier, A | 1 |
Bennis, Y | 1 |
Lenglet, G | 1 |
Avondo, C | 1 |
Lalau, JD | 1 |
Choukroun, G | 1 |
Massy, ZA | 1 |
Kamel, S | 1 |
Chillon, JM | 1 |
Hénaut, L | 1 |
Liu, Y | 1 |
Tang, G | 1 |
Li, Y | 1 |
Wang, Y | 2 |
Chen, X | 1 |
Gu, X | 1 |
Zhang, Z | 1 |
Yang, GY | 1 |
2 other studies available for metformin and Anterior Cerebral Circulation Infarction
Article | Year |
---|---|
Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease.
Topics: Adenylate Kinase; Animals; Apoptosis; Body Weight; Brain Infarction; Enzyme Activation; Female; Gene | 2021 |
Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion.
Topics: AMP-Activated Protein Kinases; Animals; Blood-Brain Barrier; Brain Infarction; Cells, Cultured; Cyto | 2014 |